Methicillin-resistance of Staphylococcus aureus in Abidjan (1998-2001):: a new hospital problem

被引:9
作者
Akoua-Koffi, C
Guessennd, N
Gbonon, V
Faye-Ketté, H
Dosso, M
机构
[1] CHU Yopougon, Inst Pasteur, UFR Sci Med Abidjan, Lab Bacteriol Virol, Abidjan 01, Cote Ivoire
[2] CHU Yopougon, Cent Lab, Lab Bacteriol Virol, Abidjan, Cote Ivoire
来源
MEDECINE ET MALADIES INFECTIEUSES | 2004年 / 34卷 / 03期
关键词
MRSA; multiresistance; nosocomial infection;
D O I
10.1016/j.medmal.2003.12.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective. - The authors had for aim to determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains on infections in Abidjan as well as their susceptibility to other antibiotics. Methods. - Three hundred and forty strains of S. aureus from various samples of hospitalized patients were studied. Methicillin-resistance was assessed using oxacillin disk diffusion in agar. The MRSA, once detected, were confirmed by screening in Mueller-Hinton agar containing oxacillin at 6 mug/ml. The susceptibility to other antibiotics was analyzed using an antibiogram in agar medium. Results. - Twenty-five percent of strains were resistant to methicillin (MRSA strains). Those MRSA were identified mainly in blood culture (14.2%), pus (4%) and urine (1.9%). Samples were collected in neonatal unit (13%), surgical units (5.4%) and intensive care unit (3.4%). A variable proportion of MRSA expressed resistance to other families of antibiotics: aminoglycosides 77.6%, rifampicin 8.8%, fluoroquinolones 34.1% and vancomycin 5.9%. Conclusion. - Circulation of multidrug resistant MRSA in hospital, especially in neonatal unit, should lead to surveillance. Risk factors and other associated markers need to be identified. (C) 2003 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 27 条
[1]  
Alpuche-Aranda C, 1989, Bol Med Hosp Infant Mex, V46, P700
[2]  
AVRIL JL, 2000, STAPHYLOCOCCUS, P3
[3]  
BERCHE P, 1988, BACTERIOLOGIE, P267
[4]  
BERTRAND X, 2001, OBSERVATION MORBIDIT
[5]  
BISMUTH R, 1999, ANN CONTROLE NAT QUA, P27
[6]  
BOYCE JM, 1990, INFECT CONT HOSP EP, V11, P639
[7]  
BRUN Y, 2000, STAPHYLACOCCUS PRECI, P783
[8]  
CARBONELLE B, 1987, STAPHYLOCOQUES BACTE, P324
[9]  
Commission of the European Communities, 2003, COMM COMM COUNC EUR, P32
[10]  
COURVALLIN P, 1985, ANTIBIOGRAMME BACTER, P333